Amphastar Pharmaceuticals (AMPH) Stock
Amphastar Pharmaceuticals (AMPH) closed at $29.10 on Nov 17, 2026; its Tenet Score is 67 of 100 against 340 Healthcare peers.
4 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $29.10
- Nov 17, 2026
- Market cap
- $1.2B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- P/E
- 12.8×
- TTM through Sep 30, 2026 · as of close, Nov 16, 2026
- 52-week range
- 16.64 – 31.00
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 67/100
- Solid · 340 Healthcare peers
Industry: Drugs
Amphastar Pharmaceuticals Inc scores 67/100. Solid. Strongest on value and growth, trading at 13× earnings versus 340 Healthcare peers.
Tenet Score · vs sector
n=340Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ~ Piotroski F-Score
- ✕ Munger Compounders
- ~ Magic Formula
- ✕ Graham Defensive
- ~ Quality Compounder
13F flows & insider trades land here.
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segme…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Novavax, Inc.NVAX | 37 | $1.3B |
| Taysha Gene Therapies IncTSHA | 58 | $1.3B |
| Ocular Therapeutix IncOCUL | 51 | $1.3B |
| Innoviva IncINVA | 73 | $1.3B |
| Absci CorpABSI | 39 | $1.3B |
| Mineralys Therapeutics IncMLYS | 55 | $1.3B |
| Mannkind CorpMNKD | 29 | $1.3B |
| Omeros CorporationOMER | 31 | $1.2B |
| Opko Health IncOPK | 43 | $1.2B |
| Cronos Group IncCRON | 72 | $1.2B |
Common questions
What sector and industry is Amphastar Pharmaceuticals in?
Amphastar Pharmaceuticals is in the Healthcare sector and the Drugs industry.
What is Amphastar Pharmaceuticals' Tenet Score?
Amphastar Pharmaceuticals' Tenet Score is 67 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




